BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15350822)

  • 1. Differential properties between TRK-820 and U-50,488H on the discriminative stimulus effects in rats.
    Mori T; Nomura M; Yoshizawa K; Nagase H; Narita M; Suzuki T
    Life Sci; 2004 Oct; 75(20):2473-82. PubMed ID: 15350822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalization of NMDA-receptor antagonists to the discriminative stimulus effects of kappa-opioid receptor agonists U-50,488H, but not TRK-820 in rats.
    Mori T; Nomura M; Yoshizawa K; Nagase H; Sawaguchi T; Narita M; Suzuki T
    J Pharmacol Sci; 2006 Feb; 100(2):157-61. PubMed ID: 16474203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a newly synthesized kappa-opioid receptor agonist, TRK-820, on the discriminative stimulus and rewarding effects of cocaine in rats.
    Mori T; Nomura M; Nagase H; Narita M; Suzuki T
    Psychopharmacology (Berl); 2002 Apr; 161(1):17-22. PubMed ID: 11967626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of dopamine D2 receptor signal transduction in the discriminative stimulus effects of the κ-opioid receptor agonist U-50,488H in rats.
    Mori T; Yoshizawa K; Ueno T; Nishiwaki M; Shimizu N; Shibasaki M; Narita M; Suzuki T
    Behav Pharmacol; 2013 Aug; 24(4):275-81. PubMed ID: 23838963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRK-820, a selective kappa-opioid agonist, produces potent antinociception in cynomolgus monkeys.
    Endoh T; Tajima A; Izumimoto N; Suzuki T; Saitoh A; Suzuki T; Narita M; Kamei J; Tseng LF; Mizoguchi H; Nagase H
    Jpn J Pharmacol; 2001 Mar; 85(3):282-90. PubMed ID: 11325021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of repeated administration of TRK-820, a kappa-opioid receptor agonist, on tolerance to its antinociceptive and sedative actions.
    Suzuki T; Izumimoto N; Takezawa Y; Fujimura M; Togashi Y; Nagase H; Tanaka T; Endoh T
    Brain Res; 2004 Jan; 995(2):167-75. PubMed ID: 14672806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of mu-opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice.
    Mizoguchi H; Hung KC; Leitermann R; Narita M; Nagase H; Suzuki T; Tseng LF
    Eur J Pharmacol; 2003 Feb; 461(1):35-9. PubMed ID: 12568913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of extracellular signal-regulated kinase is critical for the discriminative stimulus effects induced by U-50,488H.
    Yoshizawa K; Narita M; Saeki M; Narita M; Isotani K; Horiuchi H; Imai S; Kuzumaki N; Suzuki T
    Synapse; 2011 Oct; 65(10):1052-61. PubMed ID: 21465566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel kappa-opioid receptor agonist, TRK-820, blocks the development of physical dependence on morphine in mice.
    Tsuji M; Takeda H; Matsumiya T; Nagase H; Yamazaki M; Narita M; Suzuki T
    Life Sci; 2000; 66(25):PL353-8. PubMed ID: 10894094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sigma-1 receptor function is critical for both the discriminative stimulus and aversive effects of the kappa-opioid receptor agonist U-50488H.
    Mori T; Yoshizawa K; Nomura M; Isotani K; Torigoe K; Tsukiyama Y; Narita M; Suzuki T
    Addict Biol; 2012 Jul; 17(4):717-24. PubMed ID: 21392175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of dopamine D2 and D3 receptors in mediating the U-50,488H discriminative cue: comparison with methamphetamine and cocaine.
    Yoshizawa K; Narita M; Mori T; Miyatake M; Isotani K; Tomiyasu S; Tsukiyama Y; Suzuki T
    Addict Biol; 2012 Nov; 17(6):949-55. PubMed ID: 21054688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel kappa-opioid receptor agonist TRK-820 has no affect on the development of antinociceptive tolerance to morphine in mice.
    Tsuji M; Yamazaki M; Takeda H; Matsumiya T; Nagase H; Tseng LF; Narita M; Suzuki T
    Eur J Pharmacol; 2000 Apr; 394(1):91-5. PubMed ID: 10771039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
    Solinas M; Goldberg SR
    Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo.
    Wang Y; Tang K; Inan S; Siebert D; Holzgrabe U; Lee DY; Huang P; Li JG; Cowan A; Liu-Chen LY
    J Pharmacol Exp Ther; 2005 Jan; 312(1):220-30. PubMed ID: 15383632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug design and synthesis of a novel kappa opioid receptor agonist with an oxabicyclo[2.2.2]octane skeleton and its pharmacology.
    Nagase H; Watanabe A; Nemoto T; Yamaotsu N; Hayashida K; Nakajima M; Hasebe K; Nakao K; Mochizuki H; Hirono S; Fujii H
    Bioorg Med Chem Lett; 2010 Jan; 20(1):121-4. PubMed ID: 19962305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of kappa-opioidergic systems on mecamylamine-precipitated nicotine-withdrawal aversion in rats.
    Ise Y; Narita M; Nagase H; Suzuki T
    Neurosci Lett; 2002 Apr; 323(2):164-6. PubMed ID: 11950518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversion.
    Liu JJ; Chiu YT; DiMattio KM; Chen C; Huang P; Gentile TA; Muschamp JW; Cowan A; Mann M; Liu-Chen LY
    Neuropsychopharmacology; 2019 Apr; 44(5):939-949. PubMed ID: 30082888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing morphine and U-50,488H as discriminative stimuli in a three-choice assay with pigeons.
    Makhay MM; Young AM; Poling A
    Exp Clin Psychopharmacol; 1998 Feb; 6(1):3-9. PubMed ID: 9526141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.